Albireo Pharma (NASDAQ:ALBO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:30 AM.
Here's what investors need to know about the announcement.
Earnings
Albireo Pharma beat estimated earnings by 57.78%, reporting an EPS of $-0.57 versus an estimate of $-1.35.
Revenue was up $29.80 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.65 which was followed by a 2.98% increase in the share price the next day.
Here's a look at Albireo Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -1.96 | -1.77 | -1.94 |
| EPS Actual | -2.03 | -1.90 | -2.29 | -1.30 |
| Revenue Estimate | 3.48M | 1.98M | 2.13M | 2.34M |
| Revenue Actual | 3.66M | 2.43M | 1.97M | 2.72M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
